THE ROLE OF P53/MDM2 PATHWAY ABNORMALITIES IN NEUROBLASTOMA PROGNOSIS

被引：0
|
作者：
Svergun, N. [1 ]
Klymnyuk, G. [2 ]
Khranovska, N. [1 ]
Skachkova, O. [1 ]
Inomistova, M. [1 ]
Pavlyk, S. [2 ]
Shaida, O. [2 ]
机构：
[1] Natl Canc Inst MPH Ukraine, Dept Expt Oncol, Kiev, Ukraine
[2] Natl Canc Inst MPH Ukraine, Children Oncol Dept, Kiev, Ukraine
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-370
引用
收藏
页码：S336 / S336
页数：1
相关论文
共 50 条
  • [41] Modulation of the MDM2/p53 pathway during megakaryocyte differentiation.
    Datta, NS
    Long, MW
    BLOOD, 1999, 94 (10) : 270A - 270A
  • [42] Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53
    Xirodimas, DP
    Stephen, CW
    Lane, DP
    EXPERIMENTAL CELL RESEARCH, 2001, 270 (01) : 66 - 77
  • [43] Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
    Pant, Vinod
    Xiong, Shunbin
    Iwakuma, Tomoo
    Quintas-Cardama, Alfonso
    Lozano, Guillermina
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 11995 - 12000
  • [44] MDM2 is a central node in the p53 pathway: 12 years and counting
    Bond, GL
    Hu, WW
    Levine, AJ
    CURRENT CANCER DRUG TARGETS, 2005, 5 (01) : 3 - 8
  • [45] A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway
    Brignone, C
    Bradley, KE
    Kisselev, AF
    Grossman, SR
    ONCOGENE, 2004, 23 (23) : 4121 - 4129
  • [46] Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma
    Oda, Y
    Sakamoto, A
    Satio, T
    Kawauchi, S
    Iwamoto, Y
    Tsuneyoshi, M
    MODERN PATHOLOGY, 2000, 13 (09) : 994 - 1004
  • [47] A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway
    Chrystelle Brignone
    Kathleen E Bradley
    Alexei F Kisselev
    Steven R Grossman
    Oncogene, 2004, 23 : 4121 - 4129
  • [48] Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias
    Wojcik, I
    Szybka, M
    Golanska, E
    Rieske, P
    Blonski, JZ
    Robak, T
    Bartkowiak, J
    NEOPLASMA, 2005, 52 (04) : 318 - 324
  • [49] P53 α-helix mimetics antagonize p53/MDM2 interaction and activate p53
    Chen, LH
    Yin, H
    Farooqi, B
    Sebti, S
    Hamilton, AD
    Chen, JD
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (06) : 1019 - 1025
  • [50] MDM2 - arbiter of p53's destruction
    Lane, DP
    Hall, PA
    TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (10) : 372 - 374
12345